Summary

● According to Refinitiv, the company's ESG score for its industry is good.


Strengths

● Its low valuation, with P/E ratio at 8.21 and 7.41 for the ongoing fiscal year and 2024 respectively, makes the stock pretty attractive with regard to earnings multiples.

● The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.6 for the 2023 fiscal year.

● The company appears to be poorly valued given its net asset value.

● Given the positive cash flows generated by its business, the company's valuation level is an asset.

● This company will be of major interest to investors in search of a high dividend stock.

● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

● The group usually releases upbeat results with huge surprise rates.


Weaknesses

● As estimated by analysts, this group is among those businesses with the lowest growth prospects.

● The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.

● The company sustains low margins.

● For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.

● The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.

● For the past year, analysts have significantly revised downwards their profit estimates.

● For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.

● Over the past four months, analysts' average price target has been revised downwards significantly.

● The average consensus view of analysts covering the stock has deteriorated over the past four months.

● Over the past twelve months, analysts' opinions have been revised negatively.

● The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.